# Dianthus Therapeutics, Inc.: Form 8-K, filed Nov 3, 2022

- Company: [Dianthus Therapeutics, Inc.](/companies/dnth.md) (CIK 1690585)
- Form: 8-K
- Filed: 2022-11-03
- Accepted by EDGAR: Nov 3, 2022, 09:05 ET
- Period: 2022-11-03
- Accession: 0001193125-22-276477
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1690585/000119312522276477/d349418d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1690585/000119312522276477/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1690585/000119312522276477/d349418d8k.htm

Filed Nov 3, 2022.
Source: SEC EDGAR, the filing index for accession 0001193125-22-276477. Last ingested by Listed: Nov 4, 2026, 16:45 ET. No prices; not investment advice.